Skip to main content

Table 1 Criteria of inclusion and exclusion of patients.

From: HEGPOL: Randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312]

Inclusion Criteria Exclusion Criteria
Patients meeting all of the following criteria are considered for inclusion in the study: Patients presenting with any of the following are not be included in the trial:
- men and women between 18 and 65 years of age, - pregnant or nursing women,
- scheduled for first liver transplantation and graft (dead body) already available, - history of hypersensitivity to glycine or to drugs with a similar chemical structure (amino acids, e.g. serine, threonine, or methionine),
- written informed consent. - mental conditions rendering the subject incapable to understand the nature, scope, and consequences of the trial,
  - participation in another clinical trial.
  No subject will be enrolled in this study more than once.